NanoViricides (NNVC) Earnings Date & Reports

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NNVC is expected to report earnings to rise 21.43% to -17 cents per share on August 30

NanoViricides NNVC Stock Earnings Reports

Q2'23

Est.

$-0.17

Q4'24

Beat

by $0.04

Q1'24

Missed

by $0.18

Q4'23

Missed

by $0.01

Q3'23

Est.

$-0.17

The last earnings report on February 28 showed earnings per share of -14 cents, beating the estimate of -18 cents. With 34.06K shares outstanding, the current market capitalization sits at 20.86M.

View a ticker or compare two or three

Compare

NNVC